Tumor lysis syndrome in solid tumors: An up to date review of the literature

Rare Tumors

Volumn 6, Issue 2, 2014, Pages 68-75

  Mirrakhimov, Aibek E ^a   Ali, Alaa M ^a   Khan, Maliha ^a   Barbaryan, Aram ^a  

^a SAINT JOSEPH HOSPITAL   (United States)

Author keywords

Solid cancers; Tumor lysis syndrome

Indexed keywords

EID: 84903512623     PISSN: 20363605     EISSN: 20363613     Source Type: Journal    
DOI: 10.4081/rt.2014.5389     Document Type: Article

References (121)

1. Centers for Disease Control and Prevention. Deaths: preliminary data for 2011. Available from: http://www. cdc. gov/nchs/data/ nvsr/nvsr61/nvsr61_06. pdf.
2. Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004;127:3-11.
3. Wilson FP, Berns JS. Onco-nephrology: tumor lysis syndrome. Clin J Am Soc Nephrol 2012. 7:1730-9.
4. Will A, Tholouli E. The clinical management of tumour lysis syndrome in haematological malignancies. Br J Haematol 2011;154:3-13.
5. Mika D, Ahmad S, Guruvayoorappan C. Tumour lysis syndrome: implications for cancer therapy. Asian Pac J Cancer Prev 2012;13:3555-60.
6. McBride A, Westervelt P. Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies. J Hematol Oncol 2012;5:75.
7. Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 2011;31:1409-17.
8. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
9. Rezaei MK, Nolan NJ, Schwartz AM. Surgical pathology of lung cancer. Semin Respir Crit Care Med 2013;34:770-86.
10. Persons DA, Garst J, Vollmer R, Crawford J. Tumor lysis syndrome and acute renal failure after treatment of non-small-cell lung carcinoma with combination irinotecan and cisplatin. Am J Clin Oncol 1998; 21:426-9.
11. Feld J, Mehta H, Burkes RL. Acute spontaneous tumor lysis syndrome in adenocarcinoma of the lung: a case report. Am J Clin Oncol 2000;23:491-3.
12. Sewani HH, Rabatin JT. Acute tumor lysis syndrome in a patient with mixed small cell and non-small cell tumor. Mayo Clin Proc 2002;77:722-8.
13. Kurt M, Onal IK, Elkiran T, et al. Acute tumor lysis syndrome triggered by zoledronic Acid in a patient with metastatic lung adenocarcinoma. Med Oncol 2005; 22:203-6.
14. Ajzensztejn D, Hegde VS, Lee SM. Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer. J Clin Oncol 2006;24:2389-91.
15. Noh GY, Choe DH, Kim CH, Lee JC. Fatal tumor lysis syndrome during radiotherapy for non-small-cell lung cancer. J Clin Oncol 2008;26:6005-6.
16. Shenoy C. Acute spontaneous tumor lysis syndrome in a patient with squamous cell carcinoma of the lung. QJM 2009;102:71-3.
17. Honda K, Saraya T, Tamura M, et al. Tumor lysis syndrome and acquired ichthyosis occurring after chemotherapy for lung adenocarcinoma. J Clin Oncol 2011;29: 859-60.
18. Vogelzang NJ, Nelimark RA, Nath KA. Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma. JAMA 1983;249:513-4.
19. Baumann MA, Frick JC, Holoye PY. The tumor lysis syndrome. JAMA 1983;250:615.
20. Hussein AM, Feun LG. Tumor lysis syndrome after induction chemotherapy in small-cell lung carcinoma. Am J Clin Oncol 1990;13:10-3.
21. Ohnishi T, Mori K, Ohta S, et al. Tumor lysis syndrome in widely metastatic small-cell lung cancer. Int J Clin Oncol 1997;2: 235-7.
22. Kalemkerian GP, Darwish B, Varterasian ML. Tumor lysis syndrome in small cell carcinoma and other solid tumors. Am J Med 1997;103:363-7.
23. Heching N, Bonomi P. Tumor lysis syndrome in metastatic small cell cancer. Proc Am Assoc Cancer Res 1988;29:179.
24. Marinella MA. Fatal tumor lysis syndrome and gastric hemorrhage associated with metastatic small-cell lung carcinoma. Med Pediatr Oncol 1999;32:464-5.
25. Kallab AM, Jillella AP. Tumor lysis syndrome in small cell lung cancer. Med Oncol 2001;18:149-51.
26. Beriwal S, Singh S, Garcia-Young JA. Tumor lysis syndrome in extensive-stage small-cell lung cancer. Am J Clin Oncol 2002;25:474-5.
27. Mott FE, Esana A, Chakmakjian C, Herrington JD. Tumor lysis syndrome in solid tumors. Support Cancer Ther 2005;2: 188-91.
28. Jallad B, Hamdi T, Latta S, et al. Tumor lysis syndrome in small cell lung cancer: a case report and review of the literature. Onkologie 2011;34:129-31.
29. Padhi P, Singh S. Spontaneous tumor lysis syndrome in a patient with metastatic small cell carcinoma of the lung. J Cancer Sci Ther 2012;4:164-6.
30. Boikos SA, Forde PM, Chatterjee S, Hann CL. Tumor lysis syndrome in limited-stage small-cell lung cancer. J Thorac Oncol 2013; 8:e61-2.
31. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer 2005;93: 1046-52.
32. Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol 2013;24:1434-43.
33. Cech P, Block JB, Cone LA, Stone R. Tumor lysis syndrome after tamoxifen flare. N Engl J Med 1986;315:263-4.
34. Stark ME, Dyer MC, Coonley CJ. Fatal acute tumor lysis syndrome with metastatic breast carcinoma. Cancer 1987;60:762-4.
35. Barton JC. Tumor lysis syndrome in nonhematopoietic neoplasms. Cancer 1989;64: 738-40.
36. Drakos P, Bar-Ziv J, Catane R. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature. Am J Clin Oncol 1994;17:502-5.
37. Sklarin NT, Markham M. Spontaneous recurrent tumor lysis syndrome in breast cancer. Am J Clin Oncol 1995;18:71-3.
38. Ustündaǧ Y, Boyacioǧlu S, Haznedaroǧlu IC, Baltali E. Acute tumor lysis syndrome associated with paclitaxel. Ann Pharma - cother 1997;31:1548-9.
39. Rostom AY, El-Hussainy G, Kandil A, Allam A. Tumor lysis syndrome following hemibody irradiation for metastatic breast cancer. Ann Oncol 2000;111349-51.
40. Zigrossi P, Brustia M, Bobbio F, Campanini M. Flare and tumor lysis syndrome with atypical features after letrozole therapy in advanced breast cancer. A case report. Ann Ital Med Int 2001;16:112-7.
41. Kurt M, Eren OO, Engin H, Güler N. Tumor lysis syndrome following a single dose of capecitabine. Ann Pharmacother 2004; 38:902.
42. Kawaguchi Ushio A, Hattori M, Kohno N, et al. [Gemcitabine-induced tumor lysis syn- drome caused by recurrent breast cancer in a patient without hemodialysis]. Gan To Kagaku Ryoho 2013;40:1529-32. [Article in Japanese]
43. Taira F, Horimoto Y, Saito M. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature. Breast Cancer 2013 Feb 19. Epub ahead of print.
44. DeVita VT JR, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg's cancer: principles and practice of oncology. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; Ninth, North American Edition edition; 2011.
45. Bilgrami SF, Fallon BG. Tumor lysis syndrome after combination chemotherapy for ovarian cancer. Med Pediatr Oncol 1993;21:521-4.
46. Chan JK, Lin SS, McMeekin DS, Berman ML. Patients with malignancy requiring urgent therapy: CASE 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer. J Clin Oncol 2005;23:6794-5.
47. Yahata T, Nishikawa N, Aoki Y, Tanaka K. Tumor lysis syndrome associated with weekly paclitaxel treatment in a case with ovarian cancer. Gynecol Oncol 2006;103: 752-4.
48. Doi M, Okamoto Y, Yamauchi M, et al. Bleomycin-induced pulmonary fibrosis after tumor lysis syndrome in a case of advanced yolk sac tumor treated with bleomycin, etoposide and cisplatin (BEP) chemotherapy. Int J Clin Oncol 2012;17: 528-31.
49. Cui T, Wang C, He H, et al. A rare case of ovarian Burkitt lymphoma associated tumor lysis syndrome. Eur J Gynaecol Oncol 2010;31:209-10.
50. Camarata M, Davies R, Copley S, Blagden S. Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer. BMJ Case Rep 2013;2013.
51. Shamseddine AI, Khalil AM, Wehbeh MH. Acute tumor lysis syndrome with squamous cell carcinoma of the vulva. Gynecol Oncol 1993;51:258-60.
52. Khalil A, Chammas M, Shamseddine A, Seoud M. Fatal acute tumor lysis syndrome following treatment of vulvar carcinoma: case report. Eur J Gynaecol Oncol 1998;19:415-6.
53. Godoy H, Kesterson JP, Lele S. Tumor lysis syndrome associated with carboplatin and paclitaxel in a woman with recurrent endometrial cancer. Int J Gynaecol Obstet 2010;109:254.
54. Hiraizumi Y, Kamoi S, Inde Y, et al. A case of tumor lysis syndrome following chemotherapy for a uterine epithelioid leiomyosarcoma with focal rhabdomyosarcomatous differentiation. J Obstet Gynaecol Res 2011;37:947-52.
55. Schuman S, Pearson JM, Lucci JA, Twiggs LB. Metastatic gestational trophoblastic neoplasia complicated by tumor lysis syndrome, heart failure, and thyrotoxicosis: a case report. J Reprod Med 2010;55:441-4.
56. Tanvetyanon T, Choudhury AM. Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade. J Urol 2004; 171:1627.
57. Sorscher SM. Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer. Cancer Chemother Pharmacol 2004;54:191-2.
58. Wright JL, Lin DW, Dewan P, Montgomery RB. Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer. Int J Urol 2005;12:1012-3.
59. Lin CJ, Hsieh RK, Lim KH, et al. Fatal spontaneous tumor lysis syndrome in a patient with metastatic, androgen-independent prostate cancer. South Med J 2007;100:916-7.
60. Kaplan MA, Kucukoner M, Alpagat G, Isikdogan A. Tumor lysis syndrome during radiotherapy for prostate cancer with bone and bone marrow metastases without visceral metastasis. Ann Saudi Med 2012;32:306-8.
61. Blanke CD, Hemmer MP, Witte RS. Acute tumor lysis syndrome with choriocarcinoma. South Med J 2000;93:916-9.
62. Pentheroudakis G, O'Neill VJ, Vasey P, Kaye SB. Spontaneous acute tumour lysis syndrome in patients with metastatic germ cell tumours. Report of two cases. Supp Care Cancer 2001;9:554-7.
63. Feres GA, Salluh JI, Ferreira CG, Soares M. Severe acute tumor lysis syndrome in patients with germ-cell tumors. Indian J Urol 2008;24:555-7.
64. D'Alessandro V, Greco A, Clemente C, et al. Severe spontaneous acute tumor lysis syndrome and hypoglycemia in patient with germ cell tumor. Tumori 2010;96:1040-3.
65. Kattan J, Culine S, Tavakoli-Razavi T, et al. Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist? Supp Care Cancer 1994;2:128-31.
66. Lin CJ, Lim KH, Cheng YC, et al. Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma. Med Oncol 2007;24:455-7.
67. Nicholaou T, Wong R, Davis ID. Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate. Lancet 2007;369:1923-4.
68. Michels J, Lassau N, Gross-Goupil M, et al. Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma. Invest New Drugs 2010;28:690-3.
69. Rodríguez-Reimúndes E, Perazzo F, Vilches AR. [Tumor lysis syndrome in a patient with a renal carcinoma treated with sunitinib]. Medicina (B Aires) 2011;71:158-60. [Article in Spanish]
70. Lobe TE, Karkera MS, Custer MD, et al. Fatal refractory hyperkalemia due to tumor lysis during primary resection for hepatoblastoma. J Pediatr Surg 1990;25:249-50.
71. Burney IA. Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma. South Med J 1998;91:467-70.
72. Vaisban E, Braester A, Mosenzon O, et al. Spontaneous tumor lysis syndrome in solid tumors: really a rare condition? Am J Med Sci 2003;325:38-40.
73. Lehner SG, Gould JE, Saad WE, Brown DB. Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma. AJR Am J Roentgenol 2005;185:1307-9.
74. Lee CC, Wu YH, Chung SH, Chen WJ. Acute tumor lysis syndrome after thalidomide therapy in advanced hepatocellular carcinoma. Oncologist 2006; 1:87-9.
75. Sakamoto N, Monzawa S, Nagano H, et al. Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma. Cardiovasc Intervent Radiol 2007; 30:508-11.
76. Shiba H, Ishida Y, Wakiyama S, et al. Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma. Cancer Sci 2008;99:2104-5.
77. Huang WS, Yang CH. Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient. World J Gastroenterol 2009;15:4464-6.
78. Hsieh PM, Hung KC, Chen YS. Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review. World J Gastroenterol 2009;15:4726-8.
79. Bercovitz RS, Greffe BS, Hunger SP. Acute tumor lysis syndrome in a 7-month-old with hepatoblastoma. Curr Opin Pediatr 2010;22:113-6.
80. Joshita S, Yoshizawa K, Sano K, et al. A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome. Intern Med 2010;49:991-4.
81. Shiozawa K, Watanabe M, Takenaka H, et al. Tumor lysis syndrome after sorafenib for hepatocellular carcinoma: a case report. Hepatogastroenterology 2010;57: 688-90.
82. Chao CT, Chiang CK. Rasburicase for huge hepatocellular carcinoma with tumor lysis syndrome: case report. Med Princ Pract 2012;21:498-500.
83. Nishida Y, Fujii H, Hagihara A, et al. [Tumor lysis syndrome after transarterial embolization for hepatocellular carcinoma]. Nihon Shokakibyo Gakkai Zasshi 2013;110:441-8. [Article in Japanese]
84. Habib G, Nashashibi M. Fatal tumor lysis syndrome following sorafenib treatment. J Med Cases 2013;4:269-70.
85. Boisseau M, Bugat R, Mahjoubi M. Rapid tumour lysis syndrome in a metastatic colorectal cancer increased by treatment (CPT-11). Eur J Cancer 1996;32A:737-8.
86. Nikolic-Tomasevic Z, Jelic S, Popov I, Radosavljevic D. Colorectal cancer: dilemmas regarding patient selection and toxicity prediction. J Chemother 2000; 2: 244-51.
87. El Mesbahi O, Beaudoin A, Louvet C, De Gramont A. Tumor lysis syndrome after chemotherapy for colon small cell carcinoma. Rev Med Interne 2004;25:768-9.
88. Oztop I, Demirkan B, Yaren A, et al. Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan. Tumori 2004;90:514-6.
89. Hentrich M, Schiel X, Scheidt B, et al. Fatal tumor lysis syndrome after irinotecan/5- FU/folinic acid/bevacizumab-containing therapy in a patient heavily pretreated for metastatic colon cancer. Acta Oncol 2008; 47:155-6.
90. Krishnan G, D'Silva K, Al-Janadi A. Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma. J Clin Oncol 2008;26:2406-8.
91. Woo IS, Kim JS, Park MJ, et al. Spontaneous acute tumor lysis syndrome with advanced gastric cancer. J Korean Med Sci 2001;16:115-8.
92. Saylor PJ, Reid TR. Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the oral tyrosine kinase inhibitor sunitinib. J Clin Oncol 2007;25: 3544-6.
93. Pinder EM, Atwal GS, Ayantunde AA, et al. Tumour lysis syndrome occurring in a patient with metastatic gastrointestinal stromal tumour treated with glivec (imatinib mesylate, gleevec, STI571). Sarcoma 2007;2007:82012.
94. Han HS, Park SR, Kim SY, et al. Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer. J Clin Oncol 2008;26:1006-8.
95. Kobayashi T, Kuwai T, Yamamoto S, et al. [Acute tumor lysis syndrome in the setting of advanced gastric cancer]. Nihon Shokakibyo Gakkai Zasshi 2012;109:1372-8. [Article in Japanese]
96. Vodopivec DM, Rubio JE, Fornoni A, Lenz O. An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review. Case Rep Med 2012;2012: 468452.
97. Ling W, Sachdeva P, Wong AS, et al. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma. Pancreas 2012;41: 659-61.
98. Tomlinson GC, Solberg LA Jr. Acute tumor lysis syndrome with metastatic medulloblastoma. A case report. Cancer 1984;53: 1783-5.
99. Hain RD, Rayner L, Weitzman S, Lorenzana A. Acute tumour lysis syndrome complicating treatment of stage IVS neuroblastoma in infants under six months old. Med Pediatr Oncol 1994;23:136-9.
100. Kushner BH, LaQuaglia MP, Modak S, Cheung NK. Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCNamplification. Med Pediatr Oncol 2003;41:80-2.
101. Baeksgaard L, Sørensen JB. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature. Cancer Chemother Pharmacol 2003;51:187-92.
102. Dirix LY, Prove A, Becquart D, et al. Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma. Cancer 1991;67: 2207-10.
103. Minasian LM, Szatrowski TP, Rosenblum M, et al. Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor-alpha and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanoma. Blood 1994;83:56-64.
104. Castro MP, VanAuken J, Spencer-Cisek P, et al. Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: a case report and review of the literature. Cancer 1999;85: 1055-9.
105. Stoves J, Richardson D, Patel H. Tumour lysis syndrome in a patient with metastatic melanoma treated with biochemotherapy. Nephrol Dial Transplant 2001;16:188-9.
106. Habib GS, Saliba WR. Tumor lysis syndrome after hydrocortisone treatment in metastatic melanoma: a case report and review of the literature. Am J Med Sci 2002;323:155-7.
107. Busam KJ, Wolchok J, Jungbluth AA, Chapman P. Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma. J Cutan Pathol 2004;31:274-80.
108. Nakamura Y, Nakamura Y, Hori E, et al. Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma. Int J Dermatol 2009;48: 763-7.
109. Borne E, Serafi R, Piette F, Mortier L. Tumour lysis syndrome induced by corticosteroid in metastatic melanoma presenting with initial hyperkalemia. J Eur Acad Dermatol Venereol 2009;23:855-6.
110. Grenader T, Shavit L. Tumor lysis syndrome in a patient with merkel cell carcinoma and provoked pathologic sequence of acute kidney injury, reduced clearance of carboplatin and fatal pancytopenia. Onkologie 2011;34:626-9.
111. Khan J, Broadbent VA. Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma. Pediatr Hematol Oncol 1993;10:151-5.
112. Gold JE, Malamud SC, LaRosa F, Osband ME. Adoptive chemoimmunotherapy using ex vivo activated memory T-cells and cyclophosphamide: tumor lysis syndrome of a metastatic soft tissue sarcoma. Am J Hematol 1993;44:42-7.
113. Qian KQ, Ye H, Xiao YW, et al. Tumor lysis syndrome associated with chemotherapy in primary retroperitoneal soft tissue sarcoma by ex vivo ATP-based tumor chemo-sensitivity assay (ATP-TCA). Int J Gen Med 2009;2:1-4.
114. Bien E, Maciejka-Kapuscinska L, Niedzwiecki M, et al. Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases. Clin Exp Metastasis 2010;27: 399-407.
115. Crittenden DR, Ackerman GL. Hyperuricemic acute renal failure in disseminated carcinoma. Arch Intern Med 1977;137:97-9.
116. Yokoi K, Miyazawa N, Kano Y, et al. Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis. Am J Clin Oncol 1997;20:86-9.
117. Trobaugh-Lotrario AD, Liang X, Janik JS, et al. Difficult diagnostic and therapeutic cases: CASE 2. thymoma and tumor lysis syndrome in an adolescent. J Clin Oncol 2004;22:955-7.
118. Abboud M, Shamseddine A. Maxillary sinus squamous cell carcinoma presenting with fatal tumor lysis syndrome: a case report and review of the literature. Case Rep Oncol 2009;2:229-33.
119. Saini N, Pyo Lee K, Jha S, et al. Hyperuricemic renal failure in nonhematologic solid tumors: a case report and review of the literature. Case Rep Med 2012;2012:314056.
120. Cavalli R, Buffon RB, de Souza M, et al. Tumor lysis syndrome after propranolol therapy in ulcerative infantile hemangioma: rare complication or incidental finding? Dermatology 2012;224:106-9.
121. Lee JY, Lim SH, Lee JY, et al. Tumor lysis syndrome in a solid tumor: a case report of a patient with invasive thymoma. Cancer Res Treat 2013;45:343-8.